Concepedia

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

Lee-Jah Chang, Kimberly A. Dowd, Floreliz Mendoza, Jamie Saunders, Sandra Sitar, Sarah H. Plummer, Galina V. Yamshchikov, Uzma Sarwar, Zonghui Hu, Mary E. Enama,

The Lancet · 2014 · 249 citations · 26 references

DOI

Concepts

References

26

Infection with chikungunya virus in Italy: an outbreak in a temperate region

Giovanni Rezza, Loredana Nicoletti, Roberto Romi et al. · The Lancet · 2007 · 1.5K citations

, , +11

Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response

Jean‐Jacques Hoarau, Marie-Christine Jaffar Bandjee, Pascale Krejbich‐Trotot et al. · The Journal of Immunology · 2010 · 628 citations

, , +17

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

Wataru Akahata, Zhiyong Yang, Hanné Andersen et al. · Nature Medicine · 2010 · 495 citations

, , +16

Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor

Angela Chow, Zhisheng Her, Edward K. S. Ong et al. · The Journal of Infectious Diseases · 2010 · 375 citations · Full text

, , +17

Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

Robert Edelman, Carol O. Tacket, Steven S. Wasserman et al. · American Journal of Tropical Medicine and Hygiene · 2000 · 365 citations

, , +17